Finger-prick sampling for the monitoring of tacrolimus, creatinine and hemoglobin in kidney transplant recipients
Date
December 5th 2023, 17:00 CET
Location
becaris-publishing-limited.webinargeek.com/pcsig-webinar_dec23
Presentation Details
Nils Tore Vethe
Head of Section, Department of Pharmacology, Oslo University Hospital
Karsten Midtvedt
Senior physician in Nephrology, Department of Transplantation Medicine, Oslo University Hospital
Moderator: Neil Spooner
Director, Spooner Bioanalytical Solutions
Finger-prick sampling emerges as an attractive tool for therapeutic drug monitoring and associated diagnostics during follow-up in different patient populations. Kidney transplant recipients constitute a group with likely valuable gain from this concept. It is necessary to meet requirements for quality, efficiency, user-friendliness and new forms of interaction in order to achieve successful implementation in clinical practice. Aspects related to technical operations and quality, factors important for success, as well as identified challenges will be highlighted in this webinar.
Will be of interest to:
- Hospitals that consider development/implementation of home-sampling
- Laboratories involved in therapeutic drug monitoring
- Clinicians involved in therapeutic drug monitoring, especially nephrologists
- Researchers interested in new concepts for therapeutic drug monitoring and diagnostics
Sign up for the webinar here: https://becaris-publishing-limited.webinargeek.com/pcsig-webinar_dec23
The researchers at Oslo University Hospital presenting in this webinar, recently published the paper Clinical performance of volumetric finger-prick sampling for the monitoring of tacrolimus, creatinine and hemoglobin in kidney transplant recipients. Br J Clin Pharmacol. 2023 Aug 3. doi: 10.1111/bcp.15870. PMID: 37537150.
The benefits and possibilities of Capitainer®B for kidney transplant recipients are highligted.
For more background information about the work, check our blog post about the study here: Publication Highlight: Norwegian Study Confirms Feasibility of Self-Sampling with Capitainer®B for Routine Monitoring of Kidney Transplant Recipients – Capitainer
